Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33851976.
- Also identified by DOI 10.1001/jamadermatol.2021.0727 and PMC identifier 8047752.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study investigates the association of systemic corticosteroid exposures with infectious complications and survival outcomes among patients with a cutaneous immune-related adverse event.